Airborne aerosol olfactory deposition contributes to anosmia in COVID-19.

<h4>Introduction</h4>Olfactory dysfunction (OD) affects a majority of COVID-19 patients, is atypical in duration and recovery, and is associated with focal opacification and inflammation of the olfactory epithelium. Given recent increased emphasis on airborne transmission of SARS-CoV-2,...

Full description

Bibliographic Details
Main Authors: Alan D Workman, Aria Jafari, Roy Xiao, Benjamin S Bleier
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0244127
_version_ 1819030255760834560
author Alan D Workman
Aria Jafari
Roy Xiao
Benjamin S Bleier
author_facet Alan D Workman
Aria Jafari
Roy Xiao
Benjamin S Bleier
author_sort Alan D Workman
collection DOAJ
description <h4>Introduction</h4>Olfactory dysfunction (OD) affects a majority of COVID-19 patients, is atypical in duration and recovery, and is associated with focal opacification and inflammation of the olfactory epithelium. Given recent increased emphasis on airborne transmission of SARS-CoV-2, the purpose of the present study was to experimentally characterize aerosol dispersion within olfactory epithelium (OE) and respiratory epithelium (RE) in human subjects, to determine if small (sub 5μm) airborne aerosols selectively deposit in the OE.<h4>Methods</h4>Healthy adult volunteers inhaled fluorescein-labeled nebulized 0.5-5μm airborne aerosol or atomized larger aerosolized droplets (30-100μm). Particulate deposition in the OE and RE was assessed by blue-light filter modified rigid endoscopic evaluation with subsequent image randomization, processing and quantification by a blinded reviewer.<h4>Results</h4>0.5-5μm airborne aerosol deposition, as assessed by fluorescence gray value, was significantly higher in the OE than the RE bilaterally, with minimal to no deposition observed in the RE (maximum fluorescence: OE 19.5(IQR 22.5), RE 1(IQR 3.2), p<0.001; average fluorescence: OE 2.3(IQR 4.5), RE 0.1(IQR 0.2), p<0.01). Conversely, larger 30-100μm aerosolized droplet deposition was significantly greater in the RE than the OE (maximum fluorescence: OE 13(IQR 14.3), RE 38(IQR 45.5), p<0.01; average fluorescence: OE 1.9(IQR 2.1), RE 5.9(IQR 5.9), p<0.01).<h4>Conclusions</h4>Our data experimentally confirm that despite bypassing the majority of the upper airway, small-sized (0.5-5μm) airborne aerosols differentially deposit in significant concentrations within the olfactory epithelium. This provides a compelling aerodynamic mechanism to explain atypical OD in COVID-19.
first_indexed 2024-12-21T06:27:15Z
format Article
id doaj.art-cbf95e7d48f24992b7e7c58f4ba56a10
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T06:27:15Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-cbf95e7d48f24992b7e7c58f4ba56a102022-12-21T19:13:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01162e024412710.1371/journal.pone.0244127Airborne aerosol olfactory deposition contributes to anosmia in COVID-19.Alan D WorkmanAria JafariRoy XiaoBenjamin S Bleier<h4>Introduction</h4>Olfactory dysfunction (OD) affects a majority of COVID-19 patients, is atypical in duration and recovery, and is associated with focal opacification and inflammation of the olfactory epithelium. Given recent increased emphasis on airborne transmission of SARS-CoV-2, the purpose of the present study was to experimentally characterize aerosol dispersion within olfactory epithelium (OE) and respiratory epithelium (RE) in human subjects, to determine if small (sub 5μm) airborne aerosols selectively deposit in the OE.<h4>Methods</h4>Healthy adult volunteers inhaled fluorescein-labeled nebulized 0.5-5μm airborne aerosol or atomized larger aerosolized droplets (30-100μm). Particulate deposition in the OE and RE was assessed by blue-light filter modified rigid endoscopic evaluation with subsequent image randomization, processing and quantification by a blinded reviewer.<h4>Results</h4>0.5-5μm airborne aerosol deposition, as assessed by fluorescence gray value, was significantly higher in the OE than the RE bilaterally, with minimal to no deposition observed in the RE (maximum fluorescence: OE 19.5(IQR 22.5), RE 1(IQR 3.2), p<0.001; average fluorescence: OE 2.3(IQR 4.5), RE 0.1(IQR 0.2), p<0.01). Conversely, larger 30-100μm aerosolized droplet deposition was significantly greater in the RE than the OE (maximum fluorescence: OE 13(IQR 14.3), RE 38(IQR 45.5), p<0.01; average fluorescence: OE 1.9(IQR 2.1), RE 5.9(IQR 5.9), p<0.01).<h4>Conclusions</h4>Our data experimentally confirm that despite bypassing the majority of the upper airway, small-sized (0.5-5μm) airborne aerosols differentially deposit in significant concentrations within the olfactory epithelium. This provides a compelling aerodynamic mechanism to explain atypical OD in COVID-19.https://doi.org/10.1371/journal.pone.0244127
spellingShingle Alan D Workman
Aria Jafari
Roy Xiao
Benjamin S Bleier
Airborne aerosol olfactory deposition contributes to anosmia in COVID-19.
PLoS ONE
title Airborne aerosol olfactory deposition contributes to anosmia in COVID-19.
title_full Airborne aerosol olfactory deposition contributes to anosmia in COVID-19.
title_fullStr Airborne aerosol olfactory deposition contributes to anosmia in COVID-19.
title_full_unstemmed Airborne aerosol olfactory deposition contributes to anosmia in COVID-19.
title_short Airborne aerosol olfactory deposition contributes to anosmia in COVID-19.
title_sort airborne aerosol olfactory deposition contributes to anosmia in covid 19
url https://doi.org/10.1371/journal.pone.0244127
work_keys_str_mv AT alandworkman airborneaerosololfactorydepositioncontributestoanosmiaincovid19
AT ariajafari airborneaerosololfactorydepositioncontributestoanosmiaincovid19
AT royxiao airborneaerosololfactorydepositioncontributestoanosmiaincovid19
AT benjaminsbleier airborneaerosololfactorydepositioncontributestoanosmiaincovid19